Observational studyPLoS medicine2024

New pharmacodynamic parameters linked with ibrutinib responses in chronic lymphocytic leukemia: Prospective study in real-world patients and mathematical modeling.

Sarah Cadot et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.